Consideration of baseline comorbidities in studies on HER2-positive metastatic breast cancer

  • 0Department of Internal Medicine, King's Mill Hospital, Sherwood Forest Hospitals NHS Foundation Trust, Nottinghamshire NG17 4JL, United Kingdom.

|

|

Summary

No abstract available on PubMed